Evidence map›Paper›PMID 29375717›Full record

ArticleOncology letters2018

Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma.

Fei Sun, Pengcheng Wang, Yiming Zheng, Weiguang Jia, Fuxing Liu, Wei Xiao, Jingjing Bao, Song Wang, Kaijin Lu

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Selection of potential targets for stratifying congenital pulmonary airway malformation patients with molecular imaging: is MUC1 the one?European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Fei SunDepartment of Cardiothoracic Surgery, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
Pengcheng WangDepartment of Cardiothoracic Surgery, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
Yiming ZhengDepartment of Cardiothoracic Surgery, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
Weiguang JiaDepartment of Cardiothoracic Surgery, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
Fuxing LiuDepartment of Pathology, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
Wei XiaoDepartment of Pathology, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
Jingjing BaoDepartment of Pathology, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
Song WangDepartment of Cardiothoracic Surgery, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
Kaijin LuDepartment of Cardiothoracic Surgery, Taizhou People's Hospital, Taizhou, Jiangsu 225300, P.R. China.
Taizhou People's Hospital · CNNantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary pulmonary mucinous adenocarcinoma (PPMA) is an uncommon subtype of lung adenocarcinoma. The present study attempted to clarify the diagnosis, clinicopathological characteristics, and pathologic significance of epithelial growth factor receptor (EGFR) and Kirsten rat sarcoma viral oncogene (KRAS) mutations and the prognosis of PPMA. A total of 29 patients with PPMA from among 1,469 surgically resected patients with lung adenocarcinoma were enrolled. All of the tumours expressed CK7 and 5 cases exhibited co-expression with CK20. A total of 8 cases expressed EGFR, 14 cases expressed P53 and 2 cases expressed CEA. The majority of mucinous adenocarcinomas expressed thyroid transcription factor 1, Napsin A, Villin and Cam5.2 proteins. KRAS mutations were observed in 62% of patients and were more prevalent in the lower lung lobe and in patients with invasive mucinous adenocarcinoma. A total of 2 cases exhibited an EGFR mutation, and the co-mutation of KRAS and EGFR was only detected in 1 case. The relapse-free and overall survival rates at 5 years were 70.4, and 81.5%, respectively. The results may assist to identify a molecular target and supply important information for a therapeutic strategy for patients with PPMA.

Indexed as

epithelial growth factor receptorKirsten rat sarcoma viral oncogenemucinous adenocarcinoma

Identifiers

PMID29375717
PMCPMC5766062
OpenAlexW2767030895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.